Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hristo L Svilenov

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Molecular Pharmaceutics|February 5, 2025
Voices in <i>Molecular Pharmaceutics</i>: Meet Professor Hristo Svilenov who Seeks to Improve Protein Therapeutics through Formulation and Advanced Characterization TechniquesHristo L Svilenov
Structure (London, England : 1993)|January 7, 2023
Get what you want: Identifying antibodies against pre-defined epitopes on Frizzled receptorsHristo L Svilenov
Journal of Pharmaceutical Sciences|March 21, 2020
Formulations That Suppress Aggregation During Long-Term Storage of a Bispecific Antibody are Characterized by High Refoldability and Colloidal StabilityHristo L Svilenov, Gerhard Winter
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 16, 2025
Understanding IgM Structure and Biology to Engineer New Antibody TherapeuticsJohannes Buchner, Roberto Sitia, Hristo L Svilenov
Journal of Pharmaceutical Sciences|May 22, 2022
It is Never Too Late for a Cocktail - Development and Analytical Characterization of Fixed-dose Antibody CombinationsDennis Krieg, Gerhard Winter, Hristo L Svilenov
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 14, 2020
Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteinsMatja Zalar, Hristo L Svilenov, Alexander P Golovanov
Journal of Pharmaceutical Sciences|December 25, 2025
A pharmaceutical developability perspective on antibodies with ultra-long CDRsMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 21, 2025
Editorial: Honoring Prof. Gerhard Winter with the LMU Winter-Workshop special issueOlivia M Merkel, Hristo L Svilenov, Wolfgang Frieß
Biotechnology Advances|February 10, 2023
Principles of antibodies with ultralong complementarity-determining regions and picobodiesMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
Molecular Pharmaceutics|May 14, 2020
Modulated Scanning Fluorimetry Can Quickly Assess Thermal Protein Unfolding Reversibility in Microvolume SamplesHristo L Svilenov, Tim Menzen, Klaus Richter, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Molecular Pharmaceutics|February 5, 2025
Voices in <i>Molecular Pharmaceutics</i>: Meet Professor Hristo Svilenov who Seeks to Improve Protein Therapeutics through Formulation and Advanced Characterization TechniquesHristo L Svilenov
Structure (London, England : 1993)|January 7, 2023
Get what you want: Identifying antibodies against pre-defined epitopes on Frizzled receptorsHristo L Svilenov
Journal of Pharmaceutical Sciences|March 21, 2020
Formulations That Suppress Aggregation During Long-Term Storage of a Bispecific Antibody are Characterized by High Refoldability and Colloidal StabilityHristo L Svilenov, Gerhard Winter
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 16, 2025
Understanding IgM Structure and Biology to Engineer New Antibody TherapeuticsJohannes Buchner, Roberto Sitia, Hristo L Svilenov
Journal of Pharmaceutical Sciences|May 22, 2022
It is Never Too Late for a Cocktail - Development and Analytical Characterization of Fixed-dose Antibody CombinationsDennis Krieg, Gerhard Winter, Hristo L Svilenov
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|April 14, 2020
Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteinsMatja Zalar, Hristo L Svilenov, Alexander P Golovanov
Journal of Pharmaceutical Sciences|December 25, 2025
A pharmaceutical developability perspective on antibodies with ultra-long CDRsMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 21, 2025
Editorial: Honoring Prof. Gerhard Winter with the LMU Winter-Workshop special issueOlivia M Merkel, Hristo L Svilenov, Wolfgang Frieß
Biotechnology Advances|February 10, 2023
Principles of antibodies with ultralong complementarity-determining regions and picobodiesMarcel Passon, Stefaan De Smedt, Hristo L Svilenov
Molecular Pharmaceutics|May 14, 2020
Modulated Scanning Fluorimetry Can Quickly Assess Thermal Protein Unfolding Reversibility in Microvolume SamplesHristo L Svilenov, Tim Menzen, Klaus Richter, et al.
Pageof 4